Cytiva Increasing Manufacturing Capabilities In Parallel With COVID-19 R&D Surge
Executive Summary
Emmanuel Ligner, president and CEO of Cytiva, talks to In Vivo about how the company will dramatically increase its manufacturing capabilities over the next five years, at a price tag of $500m.